patient enrollment milestone

Advertisement

cGxPJobs Banner

Cardiol Reaches 50% Enrollment in Phase III MAVERIC Trial

Toronto, Jan. 13, 2026 — Cardiol Therapeutics Inc. announced that it has surpassed the 50% patient enrollment milestone in...

By cGxPwire Editor
January 13, 2026

Read More

Advertisement

cGxPJobs

Directory